Interstitial lung abnormalities progression upon treatment with cabazitaxel for metastatic prostate cancer

Read full text
Authors: Martyna Pniaczek, Stanisław Boznański, Natalia Kowalska, Emil Szmalec, Aleksandra Wojnarska, Krzysztof Sładek
Cited by: 1

Abstract

A 75-year-old patient, a never-smoker, was treated for metastatic prostate cancer.Since 2018, he has subsequently undergone therapy with docetaxel, abiraterone, and olaparib.Due to bone metastasis, radiotherapy with Ra223 was performed.Since June 2025, 6 cycles of palliative

Fields of Study & Subjects

Prostate Cancer Treatment and Research Lung Cancer Treatments and Mutations Lung Cancer Research Studies

Publication details

Journal / source
Polskie Archiwum Medycyny Wewnętrznej
Publisher
"Medycyna Praktyczna" Spolka Jawna
Volume
136
Issue
5
Publication date
4 May 2026
Language
EN